These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 15681062

  • 1. The cysteine residues of the hepatitis B virus onco-protein HBx are not required for its interaction with RNA or with human p53.
    de Moura PR, Rui E, de Almeida Gonçalves K, Kobarg J.
    Virus Res; 2005 Mar; 108(1-2):121-31. PubMed ID: 15681062
    [Abstract] [Full Text] [Related]

  • 2. Expression and spectroscopic analysis of a mutant hepatitis B virus onco-protein HBx without cysteine residues.
    Rui E, Moura PR, Gonçalves Kde A, Kobarg J.
    J Virol Methods; 2005 Jun; 126(1-2):65-74. PubMed ID: 15847920
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, Brechot C, Harris CC.
    Oncogene; 2001 Jun 21; 20(28):3620-8. PubMed ID: 11439325
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death.
    Leupin O, Bontron S, Schaeffer C, Strubin M.
    J Virol; 2005 Apr 21; 79(7):4238-45. PubMed ID: 15767425
    [Abstract] [Full Text] [Related]

  • 5. Interaction of the hepatitis B virus protein HBx with the human transcription regulatory protein p120E4F in vitro.
    Rui E, Moura PR, Gonçalves KA, Rooney RJ, Kobarg J.
    Virus Res; 2006 Jan 21; 115(1):31-42. PubMed ID: 16112766
    [Abstract] [Full Text] [Related]

  • 6. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
    Kwon JA, Rho HM.
    Biol Chem; 2003 Feb 21; 384(2):203-12. PubMed ID: 12675512
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation.
    Gottlob K, Pagano S, Levrero M, Graessmann A.
    Cancer Res; 1998 Aug 15; 58(16):3566-70. PubMed ID: 9721862
    [Abstract] [Full Text] [Related]

  • 8. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN, Oon CJ, Leong AL, Koh S, Teng SW.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):885-92. PubMed ID: 11027564
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapeutic drug, adriamycin, restores the function of p53 protein in hepatitis B virus X (HBx) protein-expressing liver cells.
    Yun C, Lee JH, Park H, Jin YM, Park S, Park K, Cho H.
    Oncogene; 2000 Oct 26; 19(45):5163-72. PubMed ID: 11064453
    [Abstract] [Full Text] [Related]

  • 10. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
    Choi M, Lee H, Rho HM.
    IUBMB Life; 2002 Jun 26; 53(6):309-17. PubMed ID: 12625370
    [Abstract] [Full Text] [Related]

  • 11. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
    Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Stürzbecher HW, Hoeijmakers JH, Harris CC.
    Cancer Res; 1995 Dec 15; 55(24):6012-6. PubMed ID: 8521383
    [Abstract] [Full Text] [Related]

  • 12. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct.
    Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S.
    Cancer Res; 1997 Nov 15; 57(22):5137-42. PubMed ID: 9371515
    [Abstract] [Full Text] [Related]

  • 13. p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.
    Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA.
    Oncogene; 1998 Oct 22; 17(16):2115-23. PubMed ID: 9798683
    [Abstract] [Full Text] [Related]

  • 14. Hepatitis B virus X protein partially substitutes for E1A transcriptional function during adenovirus infection.
    Schaack J, Maguire HF, Siddiqui A.
    Virology; 1996 Feb 15; 216(2):425-30. PubMed ID: 8607273
    [Abstract] [Full Text] [Related]

  • 15. Expression of deletion mutants of the hepatitis B virus protein HBx in E. coli and characterization of their RNA binding activities.
    Rui E, de Moura PR, Kobarg J.
    Virus Res; 2001 Apr 15; 74(1-2):59-73. PubMed ID: 11226575
    [Abstract] [Full Text] [Related]

  • 16. Turnover of hepatitis B virus X protein is facilitated by Hdj1, a human Hsp40/DnaJ protein.
    Sohn SY, Kim JH, Baek KW, Ryu WS, Ahn BY.
    Biochem Biophys Res Commun; 2006 Sep 01; 347(3):764-8. PubMed ID: 16842747
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function.
    Hsieh JL, Wu CL, Lee CH, Shiau AL.
    Clin Cancer Res; 2003 Jan 01; 9(1):338-45. PubMed ID: 12538486
    [Abstract] [Full Text] [Related]

  • 18. COX-2 mediates hepatitis B virus X protein abrogation of p53-induced apoptosis.
    Cheng AS, Yu J, Lai PB, Chan HL, Sung JJ.
    Biochem Biophys Res Commun; 2008 Sep 19; 374(2):175-80. PubMed ID: 18601905
    [Abstract] [Full Text] [Related]

  • 19. Identification of functionally important amino acid residues in the mitochondria targeting sequence of hepatitis B virus X protein.
    Li SK, Ho SF, Tsui KW, Fung KP, Waye MY.
    Virology; 2008 Nov 10; 381(1):81-8. PubMed ID: 18805561
    [Abstract] [Full Text] [Related]

  • 20. Role of V protein RNA binding in inhibition of measles virus minigenome replication.
    Parks CL, Witko SE, Kotash C, Lin SL, Sidhu MS, Udem SA.
    Virology; 2006 Apr 25; 348(1):96-106. PubMed ID: 16442140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.